Under the control of CAG promoter, TALE-VP64 enhanced FXN gene expression by 1.6–1.9-fold and mature frataxin protein expression by 1.4-fold in FRDA patient-derived fibroblasts (Tremblay et al., 2012). This evidence concerns the gene FXN and Friedreich ataxia.